首頁 > 市場調查報告書 > 醫療設備

麻醉

市場調查報告書

商品編碼

1634172

全球麻醉和呼吸設備市場

Global Anesthesia and Respiratory Devices Market

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球麻醉和呼吸設備市場規模達到540億美元，預計2033年將達到939.2億美元，2025-2033年預測期間複合年成長率為6.6%。

麻醉和呼吸設備在當代醫療保健中至關重要，尤其是在手術和重症監護場景中。這些設備可確保患者在需要麻醉或呼吸支持的治療期間安全舒適。麻醉設備是提供病人麻醉氣體和氧氣的受控混合物的醫療設備。該設備有助於在手術過程中誘導和維持麻醉，使患者保持無意識和無痛，同時監測和支持其基本功能。呼吸裝置包括各種有助於促進或控制無法自行充分呼吸的人的呼吸的設備。這包括呼吸器、氧氣輸送系統和其他控制肺部氣流和氣體交換的設備。

對麻醉和呼吸設備的需求不斷成長是預測期內推動市場的促進因素。技術進步提高了設備效率並增加了對麻醉和呼吸設備的需求，這有助於呼吸和麻醉參數的治療和診斷。例如，2024 年 8 月，Prevounce Health 宣布推出首款用於遠端病患監測 (RPM) 的血氧設備 Pylo OX1-LTE。與其他脈搏血氧計相比，經過臨床驗證的蜂窩連接OX1-LTE 為因慢性呼吸系統疾病（例如慢性阻塞性肺病(COPD) 或哮喘以及各種其他情況）參加RPM 計劃的患者提供了眾多優勢。

市場動態：

驅動程式和限制

對麻醉和呼吸設備的需求不斷增加

對麻醉和呼吸設備的需求不斷成長預計將成為全球麻醉和呼吸設備市場成長的重要因素。對麻醉和呼吸設備的需求不斷增加是由於外科手術數量的增加、呼吸系統疾病的增加、技術的進步、最近的產品發布和批准。

國際上進行的外科手術數量顯著增加。隨著手術技術的發展和擇期手術變得越來越普遍，醫療保健從業者越來越依賴先進的麻醉和呼吸設備來提高病患的安全和結果。這些設備在各種手術過程中提供麻醉、維持呼吸道通暢和輔助呼吸方面發揮重要作用。例如，根據美國國立衛生研究院的數據，美國的手術率範圍為每 10 萬人 12.0 至 21.4 例手術。

隨著慢性阻塞性肺病、氣喘和鼻竇炎等慢性呼吸系統疾病在全球變得越來越普遍，先進的麻醉和呼吸設備對於手術和重症監護期間的有效管理是必要的。例如，根據衛生與公共服務部的數據，全球每 20 人就有 1 人患有慢性呼吸道疾病 (CRD)。東亞和南亞的 CRD 死亡率最高。中低和低社會人口指數 (SDI) 國家的 CRD 死亡率年齡標準化率最高。關於慢性呼吸道疾病 (CRD) 的新研究結果顯示，它是全球第三大死因，導致全球約 400 萬人死亡。這些人中約 60%（約 2.62 億）被診斷出患有氣喘，使其成為最常見的 CRD。自 1990 年以來，CRD 新病例數量增加了 49.0%，這主要是由於人口成長。另一方面，年齡標準化發生率下降了 5.3%。

技術進步在定義市場格局方面發揮著重要作用。製造商正致力於創建攜帶式網路設備，透過更好的資料管理和監控來改善患者護理。近年來，推出了許多採用最新技術製造的產品。例如，2024年7月，液化空氣醫療系統推出了最新的呼吸器Monnal TEO，這代表了機械通氣領域的重大進步。該呼吸器專門用於重症監護和重症監護病房，顯示致力於改善急性呼吸衰竭患者的護理。

因此，外科手術數量的增加、呼吸系統疾病的增加以及技術的進步增加了對麻醉和呼吸設備的需求並推動了市場。

設備成本高

設備成本高等因素預計將阻礙全球麻醉和呼吸設備市場。成本高的最重要原因之一是生產先進麻醉和呼吸設備的困難。這些小工具通常包含尖端技術，例如人工智慧和複雜的監控系統，這需要大量的研發投資。此外，遵守高監管標準會增加生產成本，因為製造商必須確保其產品符合安全性和功效要求。例如，根據美國國立衛生研究院的數據，與停止通氣相比，為基本情況患者提供延長機械通氣(PMV) 的每延長生命年的成本為55,460 美元，每個質量調整生命年(QALY) 的成本為82,411 美元。具體來說，PMV 規定下每 QALY 的增量成本超過 100,000 美元。

Anesthesia and respiration devices are vital in contemporary healthcare, especially in surgical and critical care scenarios. These devices keep patients safe and comfortable during treatments that need anesthesia or breathing support. Anesthesia devices are medical devices that administer a controlled mixture of anesthetic gases and oxygen to patients. This equipment aids in the induction and maintenance of anesthesia during surgical procedures, allowing patients to remain unconscious and painless while their essential functions are monitored and supported. Respiratory devices include a variety of equipment that helps facilitate or control breathing for individuals who are unable to breathe sufficiently on their own. This includes ventilators, oxygen delivery systems, and other devices that control airflow and gas exchange in the lungs.

The increasing demand for anesthesia and respiratory devices is the driving factor that drives the market over the forecast period. The technological advancements improve the device efficiency and increase the demand for anesthesia and respiratory devices which helps in the treatment and diagnosis of respiratory and anesthesia parameters. For instance, in August 2024, Prevounce Health announced the launch of its first blood oxygen device for remote patient monitoring (RPM) Pylo OX1-LTE. The clinically validated, cellular-connected OX1-LTE offers numerous advantages over other pulse oximeters for patients enrolled in RPM programs for chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, and a variety of other scenarios.

Market Dynamics: Drivers & Restraints

Increasing demand for anesthesia and respiratory devices

The increasing demand for anesthesia and respiratory devices is expected to be a significant factor in the growth of the global anesthesia and respiratory devices market. The increasing demand for anesthesia and respiratory devices is due to an increasing number of surgical procedures, an increasing number of respiratory disorders, technological advancements, recent product launches, and approvals.

There has been a significant increase in the number of surgical procedures performed internationally. Healthcare practitioners are increasingly depending on advanced anesthetic and respiratory devices to improve patient safety and results as surgical techniques evolve and elective surgeries become more common. These devices play an important role in providing anesthetic, preserving airway patency, and assisting breathing during various surgical procedures. For instance, according to the National Institute of Health, Surgical rates in the United States ranged from 12.0 to 21.4 surgeries per 100,000 people.

As chronic respiratory conditions like COPD, asthma, and sinusitis become more prevalent globally, advanced anesthesia and respiratory devices are necessary for effective management during surgeries and critical care. For instance, according to the Department of Health & Human Services, 1 in 20 people globally suffers from chronic respiratory disease (CRD). East Asia and South Asia had the highest rates of CRD mortality. Low-middle and low Socio-demographic Index (SDI) countries had the highest age-standardized rates of CRD deaths. New findings on chronic respiratory disease (CRD) now show it is the third leading cause of death globally, accounting for approximately 4 million deaths worldwide. Asthma was diagnosed in approximately 60% of these people (approximately 262 million), making it the most common CRD. Since 1990, the number of new cases of CRDs has increased by 49.0%, owing primarily to population growth. The age-standardized incidence rate, on the other hand, has decreased by 5.3%.

Technological advancements play an important part in defining the market landscape. Manufacturers are concentrating on creating portable and networked equipment that improves patient care through better data management and monitoring. In recent times, there have been many product launches that are manufactured using the latest technology. For instance, in July 2024, Air Liquide Medical Systems launched its latest ventilator, Monnal TEO, which represents a substantial advancement in mechanical ventilation. This ventilator is specifically intended for use in intensive care and critical care units, indicating a commitment to improving patient care in acute respiratory failure conditions.

So, the increasing number of surgical procedures, an increasing number of respiratory disorders, and technological advancements upsurge the demand for anesthesia and respiratory devices and drive the market.

High costs of devices

Factors such as high costs of devices are expected to hamper the global anesthesia and respiratory devices market. One of the most significant reasons for the high costs is the difficulty of producing advanced anesthetic and respiratory devices. These gadgets frequently contain cutting-edge technologies, such as artificial intelligence and complex monitoring systems, which necessitate significant investment in R&D. Additionally, compliance with high regulatory standards raises production costs since manufacturers have to ensure that their products meet safety and efficacy requirements. For instance, according to the National Institute of Health, Providing prolonged mechanical ventilation (PMV) to the base-case patient costs $55,460 for every life-year gain and $82,411 per quality-adjusted life year (QALY) when compared to stopping ventilation. Specifically, the incremental costs per QALY gained under the PMV provision topped $100,000.

Segment Analysis

The global anesthesia and respiratory devices market is segmented based on respiratory equipment, respiratory disposables, respiratory measurement devices, anesthesia machines, anesthesia disposables, end-user, and region.

Oxygen concentrator segment is expected to dominate the global anesthesia and respiratory devices market share

The oxygen concentrator segment is anticipated to dominate the global anesthesia and respiratory devices market due to a number of compelling factors. Oxygen concentrators are widely recognized for their crucial function in providing oxygen supplementation to patients with respiratory diseases. This segment's expansion is primarily driven by the increased prevalence of chronic respiratory disorders, an aging population, and technological improvements that improve the efficiency and effectiveness of these devices.

The number of cases of respiratory disorders is increasing these days due to various factors such as smoking, exposure to air pollution, allergens, and occupational hazards. For instance, according to the American Lung Association, COPD affects 11.7 million adults, resulting in hundreds of thousands of emergency department visits and tens of billions of dollars in healthcare expenses each year. Moreover, according to the Cystic Fibrosis Foundation, Cystic fibrosis affects about 40,000 children and adults in the United States (an estimated 105,000 people have been diagnosed with the disease in 94 countries), and it can affect people of any ethnic background. So, oxygen concentrators play a vital role in providing oxygen supplementation and the demand for oxygen concentrators increases due to increasing respiratory disorders.

Technological advancements have also played a significant part in increasing the demand for oxygen concentrators. Compact designs, lightweight simulations, and user-friendly interfaces have improved the accessibility and usability of these gadgets. For example, portable oxygen concentrators give patients more mobility to engage in daily activities without being attached to fixed equipment. There are recent product launches that use novel technology. For instance, in January 2024, Belluscura, a medical device developer focused on lightweight and portable oxygen enrichment technology, received approval from the Singapore Health Sciences Authority to distribute the X-PLOR portable oxygen concentrator in Singapore.

The use of oxygen concentrators in anesthesia provides greater flexibility and efficiency in controlling patient care. In an emergency or during a power outage, POCs can be used as a backup oxygen source for anesthetic machines, preventing hypoxia and maintaining continuous ventilation. The increasing prevalence of respiratory disorders, technological advancements, and recent product launches and approvals upsurged the demand for oxygen concentrators making this segment the most dominating.

Geographical Analysis

North America is expected to hold a significant position in the global anesthesia and respiratory devices market share

The dominance of the North American market in the global anesthesia and respiratory devices market is due to various factors such as advanced healthcare infrastructure, high prevalence of respiratory diseases, strategic partnerships, product launches and approvals, and increasing adoption of innovative medical technologies.

The increasing prevalence of respiratory disorders in this region increases the demand for respiratory devices. For instance, according to health.gov, respiratory diseases affect millions of people in the United States. More than 25 million people in the United States have asthma. Strategies to reduce environmental triggers and make sure people get the right medications can help prevent hospital visits for asthma. In addition, more than 16 million people in the United States have COPD (chronic obstructive pulmonary disease), which is a major cause of death. Strategies to prevent the disease, like reducing air pollution and helping people quit smoking are key to reducing deaths from COPD.

Due to the presence of top players in this region, strategic partnerships take place to improve the efficiency of various medical devices. For instance, in June 2024, Novair and American Oxygen announced a strategic partnership to develop and market ionic oxygen generators, set to revolutionize the oxygen market. As part of this strategic partnership, Novair will acquire an equity stake in American Oxygen, and the partners will set up a joint venture dedicated to the manufacture of ionic oxygen generators.

In the US, there are recent product launches of anesthesia devices. For instance, in June 2024, SOMNOmedics AG launched its latest anesthesia depth monitoring tool. The NARCOguide is a small and compact stand-alone gadget intended specifically for ambulatory environments. It may be readily mounted in the operation room using a bracket. The device is controlled using the integrated touch display. The display clearly demonstrates all data at a glance, including depth of anesthesia and blood pressure curves for progress control, current depth of anesthesia values, automatic burst suppression detection, oxygen saturation, heart rate, and blood pressure, as well as raw EEG and ECG data.

Asia Pacific is growing at the fastest pace in the global anesthesia and respiratory devices market

The Asia Pacific region is emerging as the fastest-growing market for anesthesia and respiratory devices, owing to a combination of demographic trends, increased healthcare investment, recent launches, an increasing number of surgical procedures, and an increasing prevalence of respiratory diseases.

The increasing prevalence of respiratory diseases is one of the factors that drive the market in this region. For instance, according to The International Primary Care Respiratory Group, India has one of the highest rates of chronic respiratory illness. India accounts for 15.69% of worldwide chronic respiratory diseases, whereas 30.28% of all global deaths from chronic respiratory diseases occur in India. India has the world's greatest number of COPD (Chronic Obstructive Pulmonary Disease) cases, totaling 55.23 million. India has the second-highest number of COPD-related deaths globally, accounting for almost 0.85 million.

There are recent product launches of anesthesia devices in this region. For instance, according to an article published by the Times of India in June 2024, Renowned Indian data scientists have created a new AI-powered anesthetic monitoring system in India that will enable real-time, full analysis of physiological data during surgical procedures. The new AI-powered system uses machine learning algorithms to handle data from many sources, such as EEG, ECG, and pulse oximetry, assuring accurate and timely monitoring.

Competitive Landscape

The major global players in the global anesthesia and respiratory devices market include GE HealthCare, Medtronic, Teleflex Incorporated, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Getinge AB, Smiths Group plc, Fisher & Paykel Healthcare Limited., ResMed, Inogen, Inc. among others.

Emerging Players

Aerin Medical, Circadia Health, and SeaStar Medical among others

Key Developments

In August 2023, VGM & Associates signed a new vendor agreement with O2 Concepts. With O2 Concept's innovative POC portfolio and revolutionary DNA platform, they enhance the ability to meet the evolving needs of VGM members and patients. This partnership is a step forward in our commitment to delivering exceptional respiratory solutions.
In January 2023, OxyGo, makers of portable oxygen concentrators, launched a new sleep line, complete with a CPAP, BPAP, PAP accessories, and a web-based adherence portal. The cloud provider portal gives providers secure web access to manage and monitor patient data. Providers will also have the ability to share data and statistics with physicians and other healthcare professionals. The portal works with 1st-generation OxyGo CPAP and BPAP models via card-to-cloud and will also connect with the newly available 2nd-generation Wi-Fi models.
In January 2024, Schiller Healthcare India Pvt. Ltd. launched the A-mac series, marking a significant advancement in the field of anesthesia technology in India. This new series of anesthesia workstations aims to enhance the quality and efficiency of anesthesia delivery in various medical settings, particularly in hospitals and intensive care units (ICUs).

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global anesthesia and respiratory devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Respiratory Equipment
3.2. Snippet by Respiratory Disposables
3.3. Snippet by Respiratory Measurement Devices
3.4. Snippet by Respiratory Anesthesia Machines
3.5. Snippet by Respiratory Anesthesia Disposables
3.6. Snippet by End-User
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Anesthesia and Respiratory Devices
- 4.1.3. Restraints
- 4.1.4. High Costs of Devices
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Respiratory Equipment

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 6.1.2. Market Attractiveness Index, By Respiratory Equipment
6.2. Humidifiers*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Nebulizers
6.4. Oxygen Concentrator
6.5. Positive Airway Pressure Devices
6.6. Ventilators
6.7. Reusable Resuscitators

7. By Respiratory Disposables

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 7.1.2. Market Attractiveness Index, By Respiratory Disposables
7.2. Disposable Oxygen Masks*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Tracheostomy Tubes
7.4. Oxygen Cannula

8. By Respiratory Measurement Devices

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 8.1.2. Market Attractiveness Index, By Respiratory Measurement Devices
8.2. Pulse Oximetry Systems*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capnographs
8.4. Spirometers
8.5. Peak Flowmeters

9. By Anesthesia Machines

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 9.1.2. Market Attractiveness Index, By Anesthesia Machines
9.2. Anesthesia Workstation*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Anesthesia delivery machines
9.4. Anesthesia Ventilators
9.5. Anesthesia Monitors

10. By Anesthesia Disposables

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 10.1.2. Market Attractiveness Index, By Anesthesia Disposables
10.2. Anesthesia Masks*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Anesthesia Accessories

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Service Centres
11.4. Homecare

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. The U.S.
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. UK
  - 12.3.9.3. France
  - 12.3.9.4. Italy
  - 12.3.9.5. Spain
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.8.1. Brazil
  - 12.4.8.2. Argentina
  - 12.4.8.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1. China
  - 12.5.8.2. India
  - 12.5.8.3. Japan
  - 12.5.8.4. South Korea
  - 12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. GE HealthCare*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Medtronic
14.3. Teleflex Incorporated
14.4. Koninklijke Philips N.V.
14.5. Dragerwerk AG & Co. KGaA
14.6. Getinge AB
14.7. Smiths Group plc
14.8. Fisher & Paykel Healthcare Limited.
14.9. ResMed
14.10. Inogen, Inc.

LIST NOT EXHAUSTIVE